6 January 2020
A collaboration between the Russell group (Chemistry and Pharmacology) and the Davies group (Physiology, Anatomy and Genetics) has identified, via a chemical proteomics and phenotypic profiling strategy, the arylhydrocarbon receptor (AhR) as the molecular target of ezutromid, the utrophin modulator that recently completed a Phase 2 clinical trial in Duchenne muscular dystrophy patients.
11 November 2019
The Department of Pharmacology is seeking to appoint up to two Career Development Fellows by early 2020. Aimed at outstanding experienced and early career researchers, these posts will provide space, access to facilities and support to enable the postholders to establish their own independent research programme.